BioSpace News Archive

The XO Score® Scoring Sheath was the only catheter-based technology named an award winner under the cardiovascular devices category in this year’s Medical Design Excellence Awards.

Concord Medical Services Holdings Limited, a healthcare provider specializing in cancer care, research and prevention by operating a network of medically advanced comprehensive cancer hospitals and standalone radiotherapy and diagnostic imaging centers in China, announced that as of May 25, 2021, it is late in filing its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the Securities and Exchange Commission.

AnPac Bio-Medical Science Co., Ltd., a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced that on May 17, 2021, its board of directors approved the Company to establish a joint venture together with its founder and chairman, Dr. Chris Chang Yu, and certain other individuals to develop a new cancer treatment technology and associated products.

ICON plc, a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021.

Xilio to evaluate XTX101, a tumor selective anti-CTLA-4 monoclonal antibody, in combination with KEYTRUDA® (pembrolizumab) as a treatment for patients with solid tumors

Epizyme, a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, announced that Robert Bazemore, President and Chief Executive Officer, will participate in a fireside chat during the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 2:30 p.m. ET.

Cyclerion Therapeutics, Inc. announced that Company management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 4:00 p.m. ET.

Landos Biopharma, Inc. announced that Josep Bassaganya-Riera, Chairman, President and Chief Executive Officer of Landos, will present at the upcoming Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 11:00 AM EDT.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced the completion of patient enrollment of its Phase 1 clinical trial of EYP-1901 as a potential twice-yearly sustained delivery anti-VEGF treatment targeting wet age-related macular degeneration.

Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States today announced that its financial results for the first quarter of 2021 will be released on May 31, 2021. The Company will host a conference call at 9:00am EDT on the morning of June 1, 2021 to discuss the financial results.